CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 4. The effect of succinyl acetone on TrkA, Raf, and MEK1/2 activation. PC12 cells were treated exactly as described in Fig. 3A–D . Protein extracts were subjected to Western blotting analysis with antibodies against phospho(Tyr-490)-TrkA (A), phospho(Ser-259)-Raf (B), phospho(Ser-217/221)-MEK1/2 (C), total TrkA (D), total MEK1/2 (E), and total ERK1/2 (F), respectively.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation